Effects of Low-Dose EPA-E on Glycemic Control, Lipid Profile, Lipoprotein(a), Platelet Aggregation, Viscosity, and Platelet
and Vessel Wall Interaction in NIDDM Diabetes Care May 1993 16:683-688; doi:10.2337/diacare.16.5.683
Effects of Low-Dose EPA-E on Glycemic Control, Lipid Profile, Lipoprotein(a), Platelet Aggregation, Viscosity, and Platelet
and Vessel Wall Interaction in NIDDM Diabetes Care May 1993 16:683-688; doi:10.2337/diacare.16.5.683
Lipoprotein(a) Concentration Shows Little Relationship to IDDM Complications in the Pittsburgh Epidemiology of Diabetes Complications
Study Cohort Diabetes Care May 1993 16:755-758; doi:10.2337/diacare.16.5.755
Relationship Between Glycemic Control and Collagen-Linked Advanced Glycosylation End Products in Type I Diabetes Diabetes Care May 1993 16:689-694; doi:10.2337/diacare.16.5.689
Sex Differences in the Impact of Coexistent Diabetes on Survival in Patients With Coronary Heart Disease Diabetes Care May 1993 16:708-713; doi:10.2337/diacare.16.5.708
Respiratory Function in IDDM Patients Diabetes Care May 1993 16:851-852; doi:10.2337/diacare.16.5.851
Cooper, Richard S
Sex Differences in the Impact of Coexistent Diabetes on Survival in Patients With Coronary Heart Disease Diabetes Care May 1993 16:708-713; doi:10.2337/diacare.16.5.708
Relationship Between Glycemic Control and Collagen-Linked Advanced Glycosylation End Products in Type I Diabetes Diabetes Care May 1993 16:689-694; doi:10.2337/diacare.16.5.689
Effect of Aldose Reductase Inhibitor (Tolrestat) on Urinary Albumin Excretion Rate and Glomerular Filtration Rate in IDDM
Subjects With Nephropathy Diabetes Care May 1993 16:789-795; doi:10.2337/diacare.16.5.789
Effect of Aldose Reductase Inhibitor (Tolrestat) on Urinary Albumin Excretion Rate and Glomerular Filtration Rate in IDDM
Subjects With Nephropathy Diabetes Care May 1993 16:789-795; doi:10.2337/diacare.16.5.789
Effects of Low-Dose EPA-E on Glycemic Control, Lipid Profile, Lipoprotein(a), Platelet Aggregation, Viscosity, and Platelet
and Vessel Wall Interaction in NIDDM Diabetes Care May 1993 16:683-688; doi:10.2337/diacare.16.5.683
Lipoprotein(a) Concentration Shows Little Relationship to IDDM Complications in the Pittsburgh Epidemiology of Diabetes Complications
Study Cohort Diabetes Care May 1993 16:755-758; doi:10.2337/diacare.16.5.755
Effects of Low-Dose EPA-E on Glycemic Control, Lipid Profile, Lipoprotein(a), Platelet Aggregation, Viscosity, and Platelet
and Vessel Wall Interaction in NIDDM Diabetes Care May 1993 16:683-688; doi:10.2337/diacare.16.5.683
Racial Differences in the Relationship Between Blood Pressure and Risk of Retinopathy Among Individuals With NIDDM Diabetes Care May 1993 16:748-754; doi:10.2337/diacare.16.5.748
Racial Differences in the Relationship Between Blood Pressure and Risk of Retinopathy Among Individuals With NIDDM Diabetes Care May 1993 16:748-754; doi:10.2337/diacare.16.5.748
Sex Differences in the Impact of Coexistent Diabetes on Survival in Patients With Coronary Heart Disease Diabetes Care May 1993 16:708-713; doi:10.2337/diacare.16.5.708
Survey of Physician Practice Behaviors Related to Diabetes Mellitus in the U.S.: I. Design and Methods Diabetes Care May 1993 16:759-764; doi:10.2337/diacare.16.5.759
Lipoprotein(a) and Diabetes: An update Diabetes Care May 1993 16:835-840; doi:10.2337/diacare.16.5.835
Hansen, Barbara C
Standardization of IVGTT Diabetes Care May 1993 16:847; doi:10.2337/diacare.16.5.847a
Harris, Emily L
Racial Differences in the Relationship Between Blood Pressure and Risk of Retinopathy Among Individuals With NIDDM Diabetes Care May 1993 16:748-754; doi:10.2337/diacare.16.5.748
Attitudes and Behaviors of Primary Care Physicians Regarding Tight Control of Blood Glucose in IDDM Patients Diabetes Care May 1993 16:765-772; doi:10.2337/diacare.16.5.765
Marked Decrease in Serum HDL Cholesterol Levels by Combined Probucol-Pravastatin Treatment in Hypercholesterolemic NIDDM Patients
Diabetes Care May 1993 16:849-850; doi:10.2337/diacare.16.5.849
Ikeda, Yoshio
Social and Economic Impact on Youth-Onset Diabetes in Japan Diabetes Care May 1993 16:824-827; doi:10.2337/diacare.16.5.824
Lipoprotein(a) Concentration Shows Little Relationship to IDDM Complications in the Pittsburgh Epidemiology of Diabetes Complications
Study Cohort Diabetes Care May 1993 16:755-758; doi:10.2337/diacare.16.5.755
Sex Differences in the Impact of Coexistent Diabetes on Survival in Patients With Coronary Heart Disease Diabetes Care May 1993 16:708-713; doi:10.2337/diacare.16.5.708
Hew Many People in the U.S. Have IDDM? Diabetes Care May 1993 16:841-842; doi:10.2337/diacare.16.5.841
Lee, John
Sex Differences in the Impact of Coexistent Diabetes on Survival in Patients With Coronary Heart Disease Diabetes Care May 1993 16:708-713; doi:10.2337/diacare.16.5.708
Sex Differences in the Impact of Coexistent Diabetes on Survival in Patients With Coronary Heart Disease Diabetes Care May 1993 16:708-713; doi:10.2337/diacare.16.5.708
Hew Many People in the U.S. Have IDDM? Diabetes Care May 1993 16:841-842; doi:10.2337/diacare.16.5.841
Lilja, Bo
Autonomic Neuropathy Predicts Deterioration in Glomerular Filtration Rate in Patients With IDDM Diabetes Care May 1993 16:773-779; doi:10.2337/diacare.16.5.773
Attitudes and Behaviors of Primary Care Physicians Regarding Tight Control of Blood Glucose in IDDM Patients Diabetes Care May 1993 16:765-772; doi:10.2337/diacare.16.5.765
Survey of Physician Practice Behaviors Related to Diabetes Mellitus in the U.S.: I. Design and Methods Diabetes Care May 1993 16:759-764; doi:10.2337/diacare.16.5.759
Effect of Aldose Reductase Inhibitor (Tolrestat) on Urinary Albumin Excretion Rate and Glomerular Filtration Rate in IDDM
Subjects With Nephropathy Diabetes Care May 1993 16:789-795; doi:10.2337/diacare.16.5.789
Lipoprotein(a) Concentration Shows Little Relationship to IDDM Complications in the Pittsburgh Epidemiology of Diabetes Complications
Study Cohort Diabetes Care May 1993 16:755-758; doi:10.2337/diacare.16.5.755
Lipoprotein(a) Levels in Japanese Children With IDDM Diabetes Care May 1993 16:846; doi:10.2337/diacare.16.5.846
Moore, Lynn L
Relationship Between Glycemic Control and Collagen-Linked Advanced Glycosylation End Products in Type I Diabetes Diabetes Care May 1993 16:689-694; doi:10.2337/diacare.16.5.689
Lipoprotein(a) Levels in Japanese Children With IDDM Diabetes Care May 1993 16:846; doi:10.2337/diacare.16.5.846
Orchard, Trevor J
Lipoprotein(a) Concentration Shows Little Relationship to IDDM Complications in the Pittsburgh Epidemiology of Diabetes Complications
Study Cohort Diabetes Care May 1993 16:755-758; doi:10.2337/diacare.16.5.755
Effect of Aldose Reductase Inhibitor (Tolrestat) on Urinary Albumin Excretion Rate and Glomerular Filtration Rate in IDDM
Subjects With Nephropathy Diabetes Care May 1993 16:789-795; doi:10.2337/diacare.16.5.789
Effect of Aldose Reductase Inhibitor (Tolrestat) on Urinary Albumin Excretion Rate and Glomerular Filtration Rate in IDDM
Subjects With Nephropathy Diabetes Care May 1993 16:789-795; doi:10.2337/diacare.16.5.789
Effect of Aldose Reductase Inhibitor (Tolrestat) on Urinary Albumin Excretion Rate and Glomerular Filtration Rate in IDDM
Subjects With Nephropathy Diabetes Care May 1993 16:789-795; doi:10.2337/diacare.16.5.789
Racial Differences in the Relationship Between Blood Pressure and Risk of Retinopathy Among Individuals With NIDDM Diabetes Care May 1993 16:748-754; doi:10.2337/diacare.16.5.748
Effect of Aldose Reductase Inhibitor (Tolrestat) on Urinary Albumin Excretion Rate and Glomerular Filtration Rate in IDDM
Subjects With Nephropathy Diabetes Care May 1993 16:789-795; doi:10.2337/diacare.16.5.789
Effect of Aldose Reductase Inhibitor (Tolrestat) on Urinary Albumin Excretion Rate and Glomerular Filtration Rate in IDDM
Subjects With Nephropathy Diabetes Care May 1993 16:789-795; doi:10.2337/diacare.16.5.789
Racial Differences in the Relationship Between Blood Pressure and Risk of Retinopathy Among Individuals With NIDDM Diabetes Care May 1993 16:748-754; doi:10.2337/diacare.16.5.748
Survey of Physician Practice Behaviors Related to Diabetes Mellitus in the U.S.: I. Design and Methods Diabetes Care May 1993 16:759-764; doi:10.2337/diacare.16.5.759
Survey of Physician Practice Behaviors Related to Diabetes Mellitus in the U.S.: I. Design and Methods Diabetes Care May 1993 16:759-764; doi:10.2337/diacare.16.5.759
Effects of Low-Dose EPA-E on Glycemic Control, Lipid Profile, Lipoprotein(a), Platelet Aggregation, Viscosity, and Platelet
and Vessel Wall Interaction in NIDDM Diabetes Care May 1993 16:683-688; doi:10.2337/diacare.16.5.683
Autonomic Neuropathy Predicts Deterioration in Glomerular Filtration Rate in Patients With IDDM Diabetes Care May 1993 16:773-779; doi:10.2337/diacare.16.5.773
Questionable Accuracy of a Filter Paper Method for Measuring GHb Diabetes Care May 1993 16:854-855; doi:10.2337/diacare.16.5.854
Tesauro, P
Effect of Aldose Reductase Inhibitor (Tolrestat) on Urinary Albumin Excretion Rate and Glomerular Filtration Rate in IDDM
Subjects With Nephropathy Diabetes Care May 1993 16:789-795; doi:10.2337/diacare.16.5.789
Attitudes and Behaviors of Primary Care Physicians Regarding Tight Control of Blood Glucose in IDDM Patients Diabetes Care May 1993 16:765-772; doi:10.2337/diacare.16.5.765
Lipoprotein(a) Concentration Shows Little Relationship to IDDM Complications in the Pittsburgh Epidemiology of Diabetes Complications
Study Cohort Diabetes Care May 1993 16:755-758; doi:10.2337/diacare.16.5.755
Effects of Low-Dose EPA-E on Glycemic Control, Lipid Profile, Lipoprotein(a), Platelet Aggregation, Viscosity, and Platelet
and Vessel Wall Interaction in NIDDM Diabetes Care May 1993 16:683-688; doi:10.2337/diacare.16.5.683
Effects of Low-Dose EPA-E on Glycemic Control, Lipid Profile, Lipoprotein(a), Platelet Aggregation, Viscosity, and Platelet
and Vessel Wall Interaction in NIDDM Diabetes Care May 1993 16:683-688; doi:10.2337/diacare.16.5.683